ConductScience.org, home

Paper41753631

Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus.

Zhao M and 9 others. Microorganisms, 2026. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus. Papers, record 41753631. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41753631

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus.
PubMed
Journal
Microorganisms
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao MMiao
2Rong DDongli
3Chen LLinghttps://orcid.org/0009-0001-2704-2513
4Cai SShuzhen
5Lu YYongcheng
6Dai JJingsha
7Zhang YYouxiong
8Wei XXianhu
9Yang XXiaojuan
10Wu QQingpinghttps://orcid.org/0000-0001-6503-359X

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2025A04J4149Science and Technology Projects of GuangzhouPubMed

Source PubMed

References161

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,580,95512-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.Br J Ophthalmol2021https://conductscience.org/library/papers/32580955PubMed
230,659,503Lactobacillus plantarum USM8613 Aids in Wound Healing and Suppresses Staphylococcus aureus Infection at Wound Sites.Probiotics Antimicrob Proteins2020https://conductscience.org/library/papers/30659503PubMed
335,052,963Current Status of Staphylococcal Cassette Chromosome mec (SCCmec).Antibiotics (Basel)2022https://conductscience.org/library/papers/35052963PubMed
437,760,659Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review.Antibiotics (Basel)2023https://conductscience.org/library/papers/37760659PubMed
525,384,670The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.Nat Commun2014https://conductscience.org/library/papers/25384670PubMed
612,491,202Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.Clin Infect Dis2003https://conductscience.org/library/papers/12491202PubMed
727,125,562Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.Clin Microbiol Infect2016https://conductscience.org/library/papers/27125562PubMed
820,030,476A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Pharmacotherapy2010https://conductscience.org/library/papers/20030476PubMed
923,235,831CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.Nature2013https://conductscience.org/library/papers/23235831PubMed
1038,136,768Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series.Antibiotics (Basel)2023https://conductscience.org/library/papers/38136768PubMed
1136,671,212A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism.Antibiotics (Basel)2022https://conductscience.org/library/papers/36671212PubMed
1231,721,069Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.Curr Osteoporos Rep2019https://conductscience.org/library/papers/31721069PubMed
1310,524,952Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.Clin Infect Dis1999https://conductscience.org/library/papers/10524952PubMed
1439,969,286Health benefits, antimicrobial activities, and potential applications of probiotics: A review.Medicine (Baltimore)2024https://conductscience.org/library/papers/39969286PubMed
1517,517,843Experimental phage therapy against Staphylococcus aureus in mice.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17517843PubMed
1638,839,974Advocating for phage therapy.Nat Microbiol2024https://conductscience.org/library/papers/38839974PubMed
176,112,412A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.Lancet1981https://conductscience.org/library/papers/6112412PubMed
1835,414,206Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant Staphylococcus aureus.Future Microbiol2022https://conductscience.org/library/papers/35414206PubMed
1920,065,327
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
Clin Microbiol Rev2010https://conductscience.org/library/papers/20065327PubMed
2023,376,548Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases.Immunol Lett2013https://conductscience.org/library/papers/23376548PubMed

See all 161 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42,621,978Regenerative Microbiology: Harnessing Bacterial Antagonism and Spatiotemporal Signaling for Diabetic Wound Repair.Smart Med2026https://conductscience.org/library/papers/42621978PubMed
42,614,264A comprehensive review of emerging therapeutic strategies against methicillin-resistant Staphylococcus aureus.Front Microbiol2026https://conductscience.org/library/papers/42614264PubMed
42,395,635Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era.New Microbes New Infect2026https://conductscience.org/library/papers/42395635PubMed
42,326,420Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020-2026.Front Microbiol2026https://conductscience.org/library/papers/42326420PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41753631

GET https://conductscience.org/api/papers/v1/41753631/references?page=2